Cargando…
COVID-19 Infection in Hidradenitis Suppurativa Patients: A Retrospective Study
INTRODUCTION: Hidradenitis suppurativa (HS) is associated with comorbidities that are risk factors for severe COVID-19 infection. We evaluated demographics and COVID-19 outcomes in HS patients. METHODS: HS patients with COVID-19 (HS+/COVID+) and a randomized age-, race-, and sex-matched control popu...
Autores principales: | De, Devea R., Rick, Jonathan W., Shih, Terri, Hsiao, Jennifer L., Hamzavi, Iltefat, Shi, Vivian Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025363/ https://www.ncbi.nlm.nih.gov/pubmed/37325275 http://dx.doi.org/10.1159/000529462 |
Ejemplares similares
-
Optimizing hidradenitis suppurativa clinic visits: Patient perspectives
por: Shih, Terri, et al.
Publicado: (2022) -
Infliximab in hidradenitis suppurativa: A systematic review and meta‐analysis
por: Shih, Terri, et al.
Publicado: (2022) -
Integrating primary palliative care into hidradenitis suppurativa management
por: Shih, Terri, et al.
Publicado: (2022) -
Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts
por: Rick, Jonathan W., et al.
Publicado: (2022) -
Update on hidradenitis suppurativa: connecting the tracts
por: Gill, Liza, et al.
Publicado: (2014)